Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment for severe acute respiratory distress syndrome from COVID-19.
Matthay MA, Aldrich JM, Gotts JE. Matthay MA, et al. Among authors: gotts je. Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20. Lancet Respir Med. 2020. PMID: 32203709 Free PMC article. No abstract available.
Mesenchymal stem cells and acute lung injury.
Gotts JE, Matthay MA. Gotts JE, et al. Crit Care Clin. 2011 Jul;27(3):719-33. doi: 10.1016/j.ccc.2011.04.004. Epub 2011 May 23. Crit Care Clin. 2011. PMID: 21742225 Free PMC article. Review.
Mesenchymal stem cells and the stem cell niche: a new chapter.
Gotts JE, Matthay MA. Gotts JE, et al. Am J Physiol Lung Cell Mol Physiol. 2012 Jun 1;302(11):L1147-9. doi: 10.1152/ajplung.00122.2012. Epub 2012 Apr 13. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22505672 Free article. No abstract available.
Cell therapy for lung disease: a step forward.
Gotts JE, Matthay MA. Gotts JE, et al. Chest. 2013 Jun;143(6):1525-1527. doi: 10.1378/chest.12-2993. Chest. 2013. PMID: 23732575 No abstract available.
Treating ARDS: new hope for a tough problem.
Gotts JE, Matthay MA. Gotts JE, et al. Lancet Respir Med. 2014 Feb;2(2):84-5. doi: 10.1016/S2213-2600(13)70285-6. Epub 2013 Dec 23. Lancet Respir Med. 2014. PMID: 24503258 No abstract available.
Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome.
Liu KD, Wilson JG, Zhuo H, Caballero L, McMillan ML, Fang X, Cosgrove K, Calfee CS, Lee JW, Kangelaris KN, Gotts JE, Rogers AJ, Levitt JE, Wiener-Kronish JP, Delucchi KL, Leavitt AD, McKenna DH, Thompson BT, Matthay MA. Liu KD, et al. Among authors: gotts je. Ann Intensive Care. 2014 Jul 3;4:22. doi: 10.1186/s13613-014-0022-z. eCollection 2014. Ann Intensive Care. 2014. PMID: 25593740 Free PMC article.
47 results